Halozyme Therapeutics
HALO
#2470
Rank
A$9.02 B
Marketcap
$70.96
Share price
-15.01%
Change (1 day)
14.47%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): A$0.71 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$0.94 Billion. In 2023 the company made an earning of A$0.53 Billion, an increase over its 2022 earnings that were of A$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.71 B31.83%
2023 A$0.53 B39.94%
2022 A$0.38 B0.16%
2021 A$0.38 B92.2%
2020 A$0.20 B-278.96%
2019 -A$0.12 Billion-9.45%
2018 -A$0.13 Billion-229.51%
2017 A$95.32 M-160.48%
2016 -A$0.16 Billion216.03%
2015 -A$49.87 Million-52.86%
2014 -A$0.11 Billion-18.09%
2013 -A$0.13 Billion55.88%
2012 -A$82.86 Million169.94%
2011 -A$30.7 Million-63.44%
2010 -A$83.95 Million-7.19%
2009 -A$90.45 Million15.91%
2008 -A$78.04 Million83.89%
2007 -A$42.44 Million78.1%
2006 -A$23.83 Million16%
2005 -A$20.54 Million45.24%
2004 -A$14.15 Million682.42%
2003 -A$1.81 Million1659.12%
2002 -A$0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$21.48 M-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.70 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.12 Billion-115.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.88 Billion-352.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.46 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
A$28.46 B 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA